Literature DB >> 28082253

Optimizing care for the obese patient in interventional radiology.

Dwight Aberle1, Hearns Charles, Steven Hodak, Daniel O'Neill, Rahmi Oklu, Amy R Deipolyi.   

Abstract

With the rising epidemic of obesity, interventional radiologists are treating increasing numbers of obese patients, as comorbidities associated with obesity preclude more invasive treatments. These patients are at heightened risk of vascular and oncologic disease, both of which often require interventional radiology care. Obese patients pose unique challenges in imaging, technical feasibility, and periprocedural monitoring. This review describes the technical and clinical challenges posed by this population, with proposed methods to mitigate these challenges and optimize care.

Entities:  

Mesh:

Year:  2017        PMID: 28082253      PMCID: PMC5338583          DOI: 10.5152/dir.2016.16230

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  54 in total

Review 1.  Obesity in anaesthesia and intensive care.

Authors:  J P Adams; P G Murphy
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 2.  Dose adjustment of anaesthetics in the morbidly obese.

Authors:  J Ingrande; H J M Lemmens
Journal:  Br J Anaesth       Date:  2010-12       Impact factor: 9.166

3.  NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.

Authors:  K Dhatariya; N Levy; A Kilvert; B Watson; D Cousins; D Flanagan; L Hilton; C Jairam; K Leyden; A Lipp; D Lobo; M Sinclair-Hammersley; G Rayman
Journal:  Diabet Med       Date:  2012-04       Impact factor: 4.359

4.  Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.

Authors:  Margreke J E Brill; Anne van Rongen; Aletta P I Houwink; Jacobus Burggraaf; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

5.  Risks of general anesthesia and elective operation in the hypertensive patient.

Authors:  L Goldman; D L Caldera
Journal:  Anesthesiology       Date:  1979-04       Impact factor: 7.892

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass").

Authors:  Kinichi Shibutani; Mario A Inchiosa; Keisuke Sawada; Mosses Bairamian
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

8.  Dexmedetomidine use in general anaesthesia.

Authors:  A Arcangeli; C D'Alò; R Gaspari
Journal:  Curr Drug Targets       Date:  2009-08       Impact factor: 3.465

9.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

10.  Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

Authors:  Ryosuke Tateishi; Takeshi Okanoue; Naoto Fujiwara; Kiwamu Okita; Kendo Kiyosawa; Masao Omata; Hiromitsu Kumada; Norio Hayashi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2014-06-15       Impact factor: 7.527

View more
  2 in total

Review 1.  Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.

Authors:  Vincent Cascio; Man Hon; Linda B Haramati; Animesh Gour; Peter Spiegler; Sanjeev Bhalla; Douglas S Katz
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

Review 2.  Technical challenges of imaging & image-guided interventions in obese patients.

Authors:  Raul N Uppot
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.